S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
S&P 500   4,410.13
DOW   34,364.50
QQQ   353.30
NASDAQ:DXCM

DexCom Earnings Date, Estimates, & History

$426.83
+4.73 (+1.12%)
(As of 01/24/2022 04:00 PM ET)
Add
Compare
Today's Range
$402.59
$427.55
50-Day Range
$422.10
$651.26
52-Week Range
$318.45
$659.45
Volume
1.20 million shs
Average Volume
986,786 shs
Market Capitalization
$41.37 billion
P/E Ratio
81.61
Dividend Yield
N/A
Beta
0.78

Earnings Summary

Upcoming
Earnings Date
Feb. 10
Confirmed

Actual EPS
(Oct. 28)
$0.89
Beat By $0.27

Consensus EPS
(Oct. 28)
$0.62

Last Year's Q4 EPS
(10/27/2020)
$0.94

Skip Charts & View Estimated and Actual Earnings Data

DexCom Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DexCom Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

DexCom (NASDAQ:DXCM) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20224$0.45$0.73$0.64 
Q2 20224$0.71$0.85$0.78 
Q3 20224$0.87$1.08$0.95 
Q4 20224$1.03$1.28$1.14 
FY 202216$3.06$3.94$3.50
Q1 20232$0.48$1.01$0.75 
Q2 20231$1.20$1.20$1.20 
Q3 20232$1.02$1.32$1.17 

DXCM Earnings Information

DexCom last announced its earnings results on October 28th, 2021. The medical device company reported $0.89 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.62 by $0.27. The firm had revenue of $650.20 million for the quarter, compared to analyst estimates of $617.07 million. Its quarterly revenue was up 29.8% compared to the same quarter last year. DexCom has generated $5.23 earnings per share over the last year ($5.23 diluted earnings per share) and currently has a price-to-earnings ratio of 81.6. Earnings for DexCom are expected to grow by 22.50% in the coming year, from $2.80 to $3.43 per share. DexCom has confirmed that its next quarterly earnings report will be published on Thursday, February 10th, 2022. DexCom will be holding an earnings conference call on Thursday, February 10th at 4:30 PM Eastern. Interested parties can register for or listen to the call..

DexCom (NASDAQ:DXCM) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
2/10/2022
(Confirmed)
 $0.85       
10/28/20219/30/2021$0.62$0.89+$0.27$1.07$617.07 million$650.20 million    
7/29/20216/30/2021$0.43$0.76+$0.33$0.89$548.02 million$595.10 million      
4/29/20213/31/2021$0.31$0.33+$0.02$0.25$482.67 million$505.00 million    
2/11/202112/31/2020$0.91$0.91($1.66)$558.41 million$568.90 million    
10/27/20209/30/2020$0.64$0.94+$0.30$1.15$477.22 million$500.90 million    
7/28/20206/30/2020$0.31$0.79+$0.48$1.10$415.21 million$451.80 million    
4/28/20203/31/2020$0.15$0.44+$0.29$0.67$358.34 million$405.10 million    
2/13/2020Q4 2019$0.74$1.15+$0.41$1.30$457.00 million$462.80 million    
11/6/2019Q3 2019$0.20$0.65+$0.45$0.80$348.99 million$396.30 million    
7/31/2019Q2$0.0130$0.08+$0.0670$0.28$304.40 million$336.40 million    
5/1/2019Q1 2019($0.17)($0.05)+$0.12$0.20$246.10 million$280.50 million    
2/21/201912/31/2018$0.16$0.54+$0.38$3.11$331.60 million$338.00 million    
11/6/20189/30/2018($0.12)$0.17+$0.29($0.18)$242.72 million$266.70 million  
8/1/2018Q2 2018($0.18)($0.10)+$0.08($0.54)$205.81 million$242.50 million  
5/2/2018Q1 2018($0.32)($0.32)($0.36)$172.66 million$184.40 million    
2/27/2018Q4 2017$0.03$0.10+$0.07$0.31$217.82 million$221.00 million    
11/1/2017Q3 2017($0.15)($0.04)+$0.11($0.06)$183.42 million$184.60 million
8/1/2017Q2 2017($0.23)($0.16)+$0.07($0.35)$166.54 million$170.60 million  
5/2/2017Q1 2017($0.55)($0.49)+$0.06($0.49)$143.94 million$142.30 million  
2/28/2017Q416($0.10)($0.09)+$0.01($0.09)$167.51 million$171.20 million  
11/1/2016Q316($0.14)($0.22)($0.08)($0.22)$146.09 million$148.60 million
8/2/2016Q216($0.12)($0.24)($0.12)($0.24)$132.48 million$137.30 million
4/27/2016Q116($0.20)($0.23)($0.03)($0.23)$110.37 million$116.20 million  
2/23/2016Q415$0.01$0.02+$0.01$0.02$122.93 million$130.80 million  
11/4/2015Q315($0.01)($0.07)($0.06)$0.39$97.47 million$105.20 million
8/5/2015Q215($0.03)($0.05)($0.02)($0.05)$84.74 million$93.20 million
4/29/2015Q115($0.11)($0.17)($0.06)($0.17)$71.32 million$72.80 million
2/25/2015Q414($0.03)$0.02+$0.05$0.02$79.65 million$84.30 million
11/6/2014Q314($0.05)($0.08)($0.03)($0.08)$60.20 million$67.90 million
8/6/2014Q214($0.10)($0.10)($0.11)$52.45 million$58.80 million  
5/1/2014Q114($0.08)($0.17)($0.09)($0.17)$44.15 million$47.10 million  
2/20/2014Q4 2013($0.07)($0.04)+$0.03($0.04)$48.53 million$51.30 million  
11/6/2013Q3 2013($0.13)($0.08)+$0.05($0.08)$35.90 million$42.90 million  
8/7/2013Q2 2013($0.16)($0.14)+$0.02($0.14)$31.14 million$35.80 million  
5/1/2013Q1 2013($0.17)($0.16)+$0.01($0.16)$28.26 million$29.60 million  
2/21/2013Q4 2012($0.15)($0.12)+$0.03$31.09 million$33.30 million
11/1/2012Q312($0.22)($0.25)($0.03)$23.14 million$23.10 million
8/6/2012($0.20)($0.21)($0.01)
5/2/2012($0.19)($0.21)($0.02)
2/23/2012($0.17)($0.18)($0.01)
11/2/2011($0.15)($0.20)($0.05)  
8/3/2011($0.11)($0.11)
5/3/2011($0.19)($0.19)
3/3/2011($0.19)($0.16)+$0.03  
11/4/2010Q3 2010($0.17)($0.23)($0.06)($0.23)
8/3/2010Q2 2010($0.20)($0.20)($0.20)
5/5/2010Q1 2010($0.24)($0.27)($0.03)($0.14)
3/9/2010Q4 2009($0.27)($0.25)+$0.02($0.25)
11/4/2009Q3 2009($0.32)($0.29)+$0.03($0.29)
8/3/2009Q2 2009($0.29)($0.33)($0.04)($0.33)
5/6/2009Q1 2009($0.32)($0.30)+$0.02($0.27)
3/5/2009Q4 2008($0.44)($0.45)($0.01)($0.45)
11/10/2008Q3 2008($0.46)($0.50)($0.04)($0.50)
8/5/2008Q2 2008($0.46)($0.48)($0.02)($0.48)
5/8/2008Q1 2008($0.39)($0.44)($0.05)($0.44)
3/11/2008Q4 2007($0.41)($0.43)($0.02)($0.43)
(Earnings results data provided by Zacks Investment Research)












DexCom (NASDAQ:DXCM) Earnings Frequently Asked Questions

When is DexCom's earnings date?

DexCom has confirmed that its next quarterly earnings data will be published on Thursday, February 10th, 2022. Learn more on DXCM's earnings history

Did DexCom beat their earnings estimates last quarter?

In the previous quarter, DexCom (NASDAQ:DXCM) reported $0.89 earnings per share (EPS) to beat the analysts' consensus estimate of $0.62 by $0.27. Learn more on DXCM's earnings details

How can I listen to DexCom's earnings conference call?

The conference call for DexCom's latest earnings report can be listened to online. Listen to Conference Call

How can I read DexCom's conference call transcript?

The conference call transcript for DexCom's latest earnings report can be read online. Read Transcript

How much revenue does DexCom generate each year?

DexCom (NASDAQ:DXCM) has a recorded annual revenue of $1.93 billion.

How much profit does DexCom generate each year?

DexCom (NASDAQ:DXCM) has a recorded net income of $493.60 million. DXCM has generated $5.23 earnings per share over the last four quarters.

What is DexCom's price-to-earnings ratio?

DexCom (NASDAQ:DXCM) has a trailing price-to-earnings ratio of 81.61 and a forward price-to-earnings ratio of 152.44.

What is DexCom's EPS forecast for next year?

DexCom's earnings are expected to grow from $2.80 per share to $3.43 per share in the next year, which is a 22.50% increase.

This page was last updated on 1/25/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.